Artificial liver support devices as treatment option for liver failure

Best Practice and Research: Clinical Gastroenterology

Volumn 26, Issue 1, 2012, Pages 17-26

  Nevens, Frederik ^a   Laleman, Wim ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Acute liver failure; Acute on chronic liver failure; Liver transplantation; MARS liver; Prometheus

Indexed keywords

ALBUMIN; TOXIN;

ACUTE LIVER FAILURE; ALBUMIN DIALYSIS; ARTICLE; CHRONIC LIVER FAILURE; FILTRATION; HEMODIALYSIS; HEMODYNAMICS; HEPATIC ENCEPHALOPATHY; HUMAN; INTRACRANIAL PRESSURE; JAUNDICE; LIVER TRANSPLANTATION; PORTAL HYPERTENSION;

EQUIPMENT DESIGN; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER FAILURE; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; LIVER, ARTIFICIAL; SORPTION DETOXIFICATION;

EID: 84859322465     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2012.01.002     Document Type: Article

References (38)

1. W. Laleman, A. Wilmer, P. Evenpoel, C. Verslype, J. Fevery, and F. Nevens Review article: non-biological liver support in liver failure Aliment Pharmacol Ther 23 3 2006 351 363 (Pubitemid 43382015)
2. G.J. Quinlan, G.S. Martin, and T.W. Evans Albumin: physiological properties and therapeutic potential Hepatology 41 2005 1211 1219 (Pubitemid 40770271)
3. S. Klammt, S. Mitzner, J. Stange, B. Brinkmann, B. Drewelow, and J. Emmrich Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by model for end-stage liver disease Eur J Gastroenterol Hepatol 19 3 2007 257 263
4. G. Lesaffer, R. De Smet, N. Lameire, A. Dhondt, P. Duym, and R. Vanholder Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membranes Nephrol Dial Transpl 15 2000 50 57 (Pubitemid 30037930)
5. R.A. Chamuleau, T. Deurholt, and R. Hoekstra Which are the right cells to be used in a bioartificial liver? Metab Brain Dis 20 4 2005 327 335 (Pubitemid 43029806)
6. J. Stange, W. Ramlow, S. Mitzner, R. Schmidt, and H. Klinkmann Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins Artif Organs 17 1993 809 813 (Pubitemid 23288693)
7. D. Falkenhagen, W. Strobl, G. Vogt, A. Schrefl, I. Linsberger, and F.J. Gerner Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances Artif Organs 23 1999 81 86 (Pubitemid 29047501)
8. S. Sen, R. Williams, and R. Jalan The pathophysiological basis of acute-on-chronic liver failure Liver 22 Suppl. 2 2002 5 13
9. W. Laleman, L. Verbeke, P. Meersseman, J. Wauters, J. van Pelt, and D. Cassiman Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions Expert Rev. Gastroenterol Hepatol 5 4 2011 523 537
10. J.H. Flink, D. Sprengers, B.E. Hansen, M. van Zonneveld, R.A. de Man, and S.W. Schalm Flares in chronic hepatitis B patients induced by the host or the virus? Relation to treatment response during peg-interferon (alpha)-2b therapy Gut 54 11 2005 1604 1609 (Pubitemid 41531780)
11. S.S. Hamid, M. Atiq, F. Shehzad, A. Yasmeen, T. Nissa, and A. Salam Hepatitis E virus superinfection in patients with chronic liver disease Hepatology 36 2 2002 474 478 (Pubitemid 34810369)
12. K.H. Lee, M.K. Lee, D.S. Sutedja, and S.G. Lim Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure Liver Int 25 5 2005 973 977 (Pubitemid 41404018)
13. A. Katoonizadeh, W. Laleman, C. Verslype, A. Wilmer, G. Maleux, and T. Roskams Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study Gut 59 2010 1561 1569
14. L. Verbeke, F. Nevens, and W. Laleman Acute on chronic liver failure: linking the gut, liver and systemic circulation Crit Care 15 5 2011 233
15. A. Katoonizadeh, F. Nevens, C. Verslype, J. Pirenne, and T. Roskams Liver regeneration in acute severe liver impairment: a clinicopathological correlation study Liver Int 26 10 2006 1225 1233 (Pubitemid 44741210)
16. P. Evenepoel, B. Maes, A. Wilmer, F. Nevens, J. Fevery, and D. Kuypers Detoxifying capacity and kinetics of the molecular adsorbent recycling system. Contribution of the different inbuilt filters Blood Purif 21 3 2003 244 252 (Pubitemid 36649374)
17. P. Evenepoel, W. Laleman, A. Wilmer, K. Claes, D. Kuypers, and B. Bammens Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices Artif Organs 30 4 2006 276 284
18. W. Laleman, A. Wilmer, P. Evenepoel, I. Vander Elst, M. Zeegers, and Z. Zaman Effect on the molecular adsorbent recirculating system and prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure Crit Care 10 4 2006 R108
19. W. Laleman Hemodynamic effects of albumin dialysis in patients with liver failure: for better or for worse? Therapeutic Apheresis and Dialysis 13 5 2009 384 392
20. S. Sen, P.R. Mookerjee, L.M. Cheshire, N.A. Davies, R. Williams, and R. Jalan Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis J Hepatol 43 1 2005 142 148 (Pubitemid 40805285)
21. J. Bernuau, A. Goudau, T. Poynard, F. Dubois, G. Lesage, and B. Uvonnet Multivariate analysis of prognostic factors in fulminant hepatitis Hepatology 6 1986 648 651 (Pubitemid 16038182)
22. J.G. O'Grady, G.J. Alexander, K.M. Hayllar, and R. William Early indicators of prognosis in fulminant hepatic failure Gastroenterology 97 1989 439 445 (Pubitemid 19192181)
23. A. Katoonizadeh, J. Decaestecker, A. Wilmer, R. Aerts, C. Verslype, and W. Vansteenbergen MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure Liver Int 27 3 2007 329 334 (Pubitemid 46416622)
24. R. Wiesner, E. Edwards, R. Freeman, A. Harper, R. Kim, and P. Kamth Model for end-stage liver disease (MELD) and allocation of donor livers Gastroenterology 124 1 2003 91 96 (Pubitemid 36055342)
25. J. Fernandez, M. Navasa, J. Gomez, J. Colmenero, J. Vila, and V. Arroyo Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis Hepatology 35 2002 140 148 (Pubitemid 34032554)
26. E.B. Bachli, R.A. Schuepbach, M. Maggiorini, R. Stocker, B. Mullhaupt, and E.L. Renner Artificial liver support with the molecular adsorbent circulating system: activation of coagulation and bleeding complications Liver Int 27 2007 475 484 (Pubitemid 46534569)
27. B.K. Meijers, P. Verhamme, F. Nevens, M.F. Hoylaerts, B. Bammens, and A. Wilmer Major coagulation disturbances during fractionated plasma separation and adsorption Am J Transpl 7 2007 2195 2199 (Pubitemid 47247056)
28. R. Gaspari, F. Cavaliere, L. Sollazzi, V. Perilli, I. Melchionda, and S. Agnes Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs Transpl Proc 41 1 2009 253 258
29. T. Darius, D. Monbaliu, R. Aerts, W. Laleman, T. Roskams, and W. Van Steenbergen Rescue of a marginal liver graft by sequential treatment with molecular adsorbent recirculating system and transjugular intrahepatic portosystemic shunt: a case report Transpl Proc 41 8 2009 3427 3429
30. F. Pugliese, F. Ruberto, S.M. Perrella, A. Cappannolia, K. Brunoa, and S. Martellia Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: case reports Transpl Proc 39 6 2007 2042 2044 (Pubitemid 47198824)
31. F. Saliba, C. Camus, F. Durand, P. Mathurin, B. Delafosse, and K. Barange Predictive factors of transplant free survival in patients with fulminant and sufbulminant hepatic failure: results from a randomized controlled multicenter trial J Hepatol 50 2009 S89 S90
32. T.I. Hassanien, F. Tofteng, R.S. Brown Jr., B. McGuire, P. Lynch, and R. Mehta Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis Hepatology 46 2007 1853 1862
33. S.R. Mitzner, J. Stange, S. Klammt, T. Risler, C.M. Erley, and B.D. Bader Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial Liver Transpl 6 3 2000 277 286 (Pubitemid 30317221)
34. U. Heemann, U. Treichel, J. Loock, T. Philipp, G. Gerken, and M. Malago Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study J Hepatol 36 2002 949 958
35. R. Banares, F. Nevens, F.S. Larsen, R. Jalan, A. Albillos, and M. Dollinger Extracorporeal live support with MARS in patients with acute-on-chronic liver failure. The RELIEF trial J Hepatol 52 2010 S459
36. K. Rifai, A. Kribben, G. Gerken, S. Haag, S. Herget-Rosenthal, U. Treichel HELIOS Study Group Extracorporeal liver support by fractionated plasma separation and absorption (Prometheus) in patients with acute-on-chronic liver failure (HELIOS study): a prospective randomized controlled multicenter study J Hepatol 52 2010 S3
37. J.P. Liu, L.L. Gluud, B. Als-Nielsen, and C. Gluud Artificial and bioartificial support systems for liver failure Cochrane Database Syst Rev 1 2004 CD003628
38. C.T. Wai, S.G. Lim, M.O. Aung, Y.M. Lee, D.S. Sutedja, and Y.Y. Dan MARS: a futile tool in centres without active liver transplant support Liver Int 27 1 2007 69 75 (Pubitemid 46139429)